GSRRX
Price
$11.59
Change
+$0.05 (+0.43%)
Updated
Jul 3 closing price
Net Assets
447.47M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

GSRRX vs VVIAX

Header iconGSRRX vs VVIAX Comparison
Open Charts GSRRX vs VVIAXBanner chart's image
Goldman Sachs Rising Dividend Gr R
Price$11.59
Change+$0.05 (+0.43%)
VolumeN/A
Net Assets447.47M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
GSRRX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSRRX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRRX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. GSRRX (447M). VVIAX pays higher dividends than GSRRX: VVIAX (2.18) vs GSRRX (1.22). GSRRX was incepted earlier than VVIAX: GSRRX (13 years) vs VVIAX (25 years). GSRRX (1.52) is less costly to investors than VVIAX (0.05). GSRRX is a more actively managed with annual turnover of: 42.00 vs. VVIAX (9.00). GSRRX has a lower initial minimum investment than VVIAX: GSRRX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. GSRRX (-3.48). VVIAX return over 5 years is better than : 80.13 vs. GSRRX (34.85).
GSRRXVVIAXGSRRX / VVIAX
Total Expense Ratio1.260.052,520%
Annual Report Gross Expense Ratio1.520.053,040%
Fund Existence13 years25 years-
Gain YTD5.6816.19892%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets447M189B0%
Annual Yield % from dividends1.222.1856%
Returns for 1 year-3.4812.03-29%
Returns for 3 years11.1035.1732%
Returns for 5 years34.8580.1343%
Returns for 10 years-35.81115.67-31%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.